Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the SciTech Biosciences First Quarter 2026 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number 1 on your telephone keypad. And to withdraw your question, press star 1 again. I will now turn the conference over to Paul Goodson, Head of Investor Relations. You may begin. Thank you, Operator. Earlier today, SciTech Biosciences released financial results for the first quarter ended March 31, 2026. If you haven't received this news release or if you'd like to be added to the company's distribution list, please send an email to investors at scitechbio.com. A copy of the news release is also available on the investor relations section of SciTech's website at investors.scitechbio.com. Please note that we will be referencing a slide presentation during the call today that has been posted to the investors section of our corporate website. Joining me today from SciTech are Wenbin Zhang, CEO, and Bill McComb, CFO. As a reminder, on slide two, we will make statements during this call that are forward-looking statements within the meaning of the federal securities laws, including statements regarding CITAC's business plans, strategies, opportunities, and financial projections. These statements are based on the company's current expectations and inherently involve significant risks and uncertainties that could cause actual results or events to materially differ from those anticipated in these statements. Additional information regarding these risks and uncertainties appears in ...